Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Gastrointestinal 1CNS 1

Conditions

Solid Tumor 1Rectal Neoplasms 1Pancreatic Neoplasms 1Multiple Myeloma 1Liver Neoplasms 1Glioblastoma 1Gallbladder Neoplasms 1Colonic Neoplasms 1Breast Cancer Female 1

Interventions

Oxaliplatin 4Gemcitabine 4Fluorouracil 3Capecitabine 3Tegafur 2Stents 2Radiofrequency Ablation 2Leucovorin 2Irinotecan 2toripalimab 1tislelizumab 1taxane 1surufatinib 1lenvatinib 1apixaban 1apatinib 1aldesleukin 1Urination 1Trastuzumab 1Tomography, X-Ray Computed 1Temozolomide 1Taxes 1Standard of Care 1Sorafenib 1S 1 (combination) 1Rivaroxaban 1Radiotherapy 1Polymerase Chain Reaction 1Platinum Compounds 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Gallbladder Neoplasms × Cannabidiol × Clear all
NCT03607643 2018-07-31

A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Leaf Vertical Inc.

Phase 1/2 Unknown
160 enrolled
CNSGastrointestinalPlasma cell

Colonic Neoplasms, Gallbladder Neoplasms, Glioblastoma, Liver Neoplasms, Multiple Myeloma, Pancreatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡